Cognitive enhancement as a treatment for drug addictions

M Sofuoglu, EE DeVito, AJ Waters, KM Carroll - Neuropharmacology, 2013‏ - Elsevier
Drug addiction continues to be an important public health problem, with an estimated 22.6
million current illicit drug users in the United States alone. For many addictions, including …

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials

LS Acheson, BH Williams, M Farrell… - Drug and Alcohol …, 2023‏ - Wiley Online Library
Issues Cessation of methamphetamine use may result in a characteristic withdrawal
syndrome, no medication has been approved for this indication. This systematic review aims …

Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis

C Cumming, L Troeung, JT Young, E Kelty… - Drug and alcohol …, 2016‏ - Elsevier
Background Methamphetamine use is associated with a range of poor health, social and
justice outcomes. In many parts of the world increased methamphetamine use has been …

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders

M Mereu, A Bonci, AH Newman, G Tanda - Psychopharmacology, 2013‏ - Springer
Rationale and objectives Modafinil (MOD) and its R-enantiomer (R-MOD) are approved
medications for narcolepsy and other sleep disorders. They have also been used, off-label …

Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta‐analysis of cognitive training, remediation and pharmacological …

AC Anderson, GJ Youssef, AH Robinson… - …, 2021‏ - Wiley Online Library
Aims To evaluate and compare the effects of three cognitive boosting intervention
approaches (computerised cognitive training, cognitive remediation and pharmacological …

Neuropsychological consequences of chronic drug use: relevance to treatment approaches

JL Cadet, V Bisagno - Frontiers in psychiatry, 2016‏ - frontiersin.org
Heavy use of drugs impacts of the daily activities of individuals in these activities. Several
groups of investigators have indeed documented changes in cognitive performance by …

Cognitive function as a transdiagnostic treatment target in stimulant use disorders

M Sofuoglu, EE DeVito, AJ Waters… - Journal of dual …, 2016‏ - Taylor & Francis
Stimulant use disorder is an important public health problem, with an estimated 2.1 million
current users in the United States alone. No pharmacological treatments are approved by …

Methamphetamine toxicities and clinical management

PO Coffin, LW Suen - NEJM evidence, 2023‏ - evidence.nejm.org
Methamphetamine use has increased over the past 15 years, with corresponding increases
in associated morbidity and mortality. Toxicities from methamphetamine use largely consist …

Clinical management of psychostimulant withdrawal: review of the evidence

MJ Li, SJ Shoptaw - Addiction, 2023‏ - Wiley Online Library
It is estimated that a majority of people who use psychostimulants, particularly
methamphetamine (MA) and cocaine, experience withdrawal upon abstinence from …

Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans

AC Dean, RJ Sevak, JR Monterosso… - Journal of studies on …, 2011‏ - jsad.com
Objective: Individuals who are methamphetamine dependent exhibit higher rates of
cognitive dysfunction than healthy people who do not use methamphetamine, and this …